Latest JOHNSON & JOHNSON Stock Portfolio
$798Million | No. of Holdings #15
JOHNSON & JOHNSON Performance
2026 Q2+20.53%
YTD+42.42%
2025+51.06%
About JOHNSON & JOHNSON and 13F Hedge Fund Stock Holdings
On 2026-08-06, the fund reported it's updated stock portfolio. In the 13F Holdings report, JOHNSON & JOHNSON reported an equity portfolio of $798.7 Millions as of 30 Jun, 2026. <br><br> The top stock holdings of JOHNSON & JOHNSON are PTGX, NBTX, MGTX. The fund has invested 37.6% of it's portfolio in PROTAGONIST THERAPEUTICS INC and 26.6% of portfolio in NANOBIOTIX. <br><br> The fund managers got completely rid off RALLYBIO CORPORATION (RLYB) and NANO-X IMAGING LTD. (NNOX) stocks. JOHNSON & JOHNSON opened new stock positions in CEREBRAS SYSTEMS INC.
JOHNSON & JOHNSON Equity Portfolio Value
Last Reported on: 06 Aug, 2026
$798Million
as of Aug 06, 2026JOHNSON & JOHNSON Annual Return Estimates Vs S&P 500
Our best estimate is that JOHNSON & JOHNSON made a return of 20.53% in the last quarter. In trailing 12 months, it's portfolio return was 148.62%.
- Performance
- S&P 500
New Buys
| Ticker | $ Bought |
|---|---|
| cerebras systems inc | 11,842,500 |
New stocks bought by JOHNSON & JOHNSON
Additions
No additions were made to existing positions by JOHNSON & JOHNSON
Reductions
None of the existing positions were reduced by JOHNSON & JOHNSON
Sold off
| Ticker | $ Sold |
|---|---|
| rallybio corporation | -1,371,520 |
| nano-x imaging ltd. | -189,668 |
JOHNSON & JOHNSON got rid off the above stocks
Sector Distribution
JOHNSON & JOHNSON has about 55.3% of it's holdings in Healthcare sector.
- Healthcare
- Others
| Sector | % |
|---|---|
| Healthcare | 55.3 |
| Others | 44.7 |
Market Cap. Distribution
JOHNSON & JOHNSON has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.
- UNALLOCATED
- MID-CAP
- SMALL-CAP
- MICRO-CAP
| Category | % |
|---|---|
| UNALLOCATED | 44.7 |
| MID-CAP | 37.6 |
| SMALL-CAP | 13.9 |
| MICRO-CAP | 3.8 |
Stocks belong to which Index?
About 55.2% of the stocks held by JOHNSON & JOHNSON either belong to S&P 500 or RUSSELL 2000 index.
- RUSSELL 2000
- Others
| Index | % |
|---|---|
| RUSSELL 2000 | 55.2 |
| Others | 44.8 |
JOHNSON & JOHNSON Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of JOHNSON & JOHNSON
JOHNSON & JOHNSON has 15 stocks in it's portfolio. About 98.4% of the portfolio is in top 10 stocks. CVRX proved to be the most loss making stock for the portfolio. PTGX was the most profitable stock for JOHNSON & JOHNSON last quarter.
$798.65MTotal Value
17.00Positions
06 Aug, 2026Last Reported
| Expand | Holdingsorted ascending | % Portfolio | Shares Held | $ Value | % Change |
|---|---|---|---|---|---|
 Adicet Bio Inc Adicet Bio IncACET JOHNSON & JOHNSON's holding in Adicet Bio Inc over time | 0.03% | 22,779 | $196.8K 0.03% | 0%unchanged 0 percentunchanged | |
| 2.59% | 4,024,860 | $20.69M 2.59% | 0%unchanged 0 percentunchanged | ||
 Fate Therapeutics Inc JOHNSON & JOHNSON's holding in Fate Therapeutics Inc over time | 1.14% | 3,379,060 | $9.12M 1.14% | 0%unchanged 0 percentunchanged | |
 Standard Biotools Inc JOHNSON & JOHNSON's holding in Standard Biotools Inc over time | 0.03% | 311,967 | $256.7K 0.03% | 0%unchanged 0 percentunchanged | |
 LEGN Legend Biotech CorpLegend Biotech CorpLEGN | 2.95% | 814,586 | $23.53M 2.95% | 0%unchanged 0 percentunchanged | |
 Meiragtx Hldgs Plc JOHNSON & JOHNSON's holding in Meiragtx Hldgs Plc over time | 11.23% | 6,641,060 | $89.72M 11.23% | 0%unchanged 0 percentunchanged | |
 NBTX NanobiotixNanobiotixNBTX | 26.55% | 5,623,820 | $212.02M 26.55% | 0%unchanged 0 percentunchanged | |
 NNOX Nano-X Imaging Ltd.Nano-X Imaging Ltd.NNOX | 0% | 0.00 | $0.00 0% | 100%decreased 100 percentsold off | |
 Procept Biorobotics Corp JOHNSON & JOHNSON's holding in Procept Biorobotics Corp over time | 1.01% | 357,939 | $8.08M 1.01% | 0%unchanged 0 percentunchanged | |
 Protagonist Therapeutics Inc JOHNSON & JOHNSON's holding in Protagonist Therapeutics Inc over time | 37.59% | 2,449,180 | $300.22M 37.59% | 0%unchanged 0 percentunchanged | |
 Rallybio Corporation JOHNSON & JOHNSON's holding in Rallybio Corporation over time | 0% | 0.00 | $0.00 0% | 100%decreased 100 percentsold off | |
 Vor Biopharma Inc JOHNSON & JOHNSON's holding in Vor Biopharma Inc over time | 0.12% | 53,732 | $989.2K 0.12% | 0%unchanged 0 percentunchanged | |
 Xencor Inc Xencor IncXNCR JOHNSON & JOHNSON's holding in Xencor Inc over time | 1.51% | 748,062 | $12.04M 1.51% | 0%unchanged 0 percentunchanged | |
Com Rapport Therapeutics IncRapport Therapeutics Inc | 9.31% | 1,784,520 | $74.36M 9.31% | 0%unchanged 0 percentunchanged | |
Cl A Contineum Therapeutics IncContineum Therapeutics Inc | 4.06% | 1,979,170 | $32.44M 4.06% | 0%unchanged 0 percentunchanged | |
Com Cl A Cerebras Systems IncCerebras Systems Inc | 1.48% | 53,586 | $11.84M 1.48% | Newnew position | |
Com Neumora Therapeutics Inc.Neumora Therapeutics Inc. | 0.39% | 1,849,440 | $3.14M 0.39% | 0%unchanged 0 percentunchanged | |
